(Q45870174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

mesenchymal stem cell

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Kanehira M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Xin H

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hoshino K

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Maemondo M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mizuguchi H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hayakawa T

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nakamura T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nukiwa T

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Saijo Y

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

10 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

894-903

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701079

3 January 2020

exact match

0 references

cites work

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

21 January 2018

Targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Part I: Vaccines for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Stem cells as vehicles for orthopedic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Bone marrow-derived mesenchymal stem cells in repair of the injured lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

The epidermal growth factor receptor as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

The role of interleukin-8 in cancer cells and microenvironment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Molecular mechanisms of lymphangiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

An uncleavable form of pro–scatter factor suppresses tumor growth and dissemination in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

Vector-mediated cancer gene therapy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

Human mesenchymal stem cells maintain transgene expression during expansion and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

Lentiviral transfer of the LacZ gene into human endothelial cells and human bone marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701079

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701079

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17693990%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 January 2020

0 references

1 reference